Programme theme(s): Immunology and immunotherapy
Programme session type(s): Lightning talks
Cancer sites: Bladder and renal, Breast, Lung
Interest for: Clinicians, Scientists, Trainees

This session is supported by an unrestricted educational grant from Promega UK.
They had no involvement in topic or speaker selection.
Abstract title: Retrospective review of the efficacy and tolerability of neoadjuvant biosimilar Trastuzumab (Herzuma) in combination with Pertuzumab and chemotherapy in HER2-positive early breast cancer.
Presenting author: Ciara Martin


Abstract title: Atezolizumab and Pembrolizumab Immunotherapy in the treatment of metastatic urothelial cancers – real world experience in Devon and Cornwall.
Presenting author: Hannah Bond


Abstract title: Clinical correlates of peripheral T cell immune awakening
Presenting author: Zena Salih


Abstract title: Outcomes for Advanced Non-Small Cell Lung Cancer Patients Treated with First-line Palliative Chemoimmunotherapy
Presenting author: Elinor Gatfield